Search research articles
Contact Us
Filters
Showing results (1-10 of 395) with videos related to
Page
of 40
Sort By:
Giornale Italiano Di Cardiologia (2006)
|
February 14, 2020
[The THEMIS trial]
Leonardo De Luca
Giornale Italiano Di Cardiologia (2006)
|
March 6, 2020
[Antithrombotic therapy after acute coronary syndromes: is it possible to identify the PEGASUS and COMPASS patient?]
Leonardo De Luca
JACC. Cardiovascular Interventions
|
December 22, 2018
Procedural Characteristics for the Optimization of Dual Antiplatelet Therapy Duration: Another Piece of the Puzzle?
Leonardo De Luca
International Journal of Cardiology
|
July 29, 2014
Inotropic agents in advanced heart failure: repetita iuvant?
Leonardo De Luca
Cardiovascular Drugs and Therapy
|
June 22, 2020
Established and Emerging Pharmacological Therapies for Post-Myocardial Infarction Patients with Heart Failure: a Review of the Evidence
Leonardo De Luca
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
November 10, 2016
PEGASUS study: who would benefit from prolonged DUAL antiplatelet therapy?
Leonardo De Luca
Circulation. Cardiovascular Interventions
|
September 1, 2016
Percutaneous Treatment of Coronary Bifurcation Lesions: Is Simplicity the Ultimate Sophistication?
Leonardo De Luca
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
May 1, 2023
Low-dose rivaroxaban: can cardiovascular events be reduced?
Leonardo De Luca
Giornale Italiano Di Cardiologia (2006)
|
January 15, 2019
[Five questions for the clinician after the publication of the COMPASS trial]
Leonardo De Luca
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 15, 2021
Pre-treatment with dual antiplatelet therapy in non-ST-segment elevation acute coronary syndromes: landing from guidelines recommendations to real-world ground
Leonardo De Luca
Page
of 40
Search research articles
Search
Showing results (1-10 of 395) with videos related to
Sort By:
Page
of 40
Giornale Italiano Di Cardiologia (2006)
|
February 14, 2020
[The THEMIS trial]
Leonardo De Luca
Giornale Italiano Di Cardiologia (2006)
|
March 6, 2020
[Antithrombotic therapy after acute coronary syndromes: is it possible to identify the PEGASUS and COMPASS patient?]
Leonardo De Luca
JACC. Cardiovascular Interventions
|
December 22, 2018
Procedural Characteristics for the Optimization of Dual Antiplatelet Therapy Duration: Another Piece of the Puzzle?
Leonardo De Luca
International Journal of Cardiology
|
July 29, 2014
Inotropic agents in advanced heart failure: repetita iuvant?
Leonardo De Luca
Cardiovascular Drugs and Therapy
|
June 22, 2020
Established and Emerging Pharmacological Therapies for Post-Myocardial Infarction Patients with Heart Failure: a Review of the Evidence
Leonardo De Luca
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
November 10, 2016
PEGASUS study: who would benefit from prolonged DUAL antiplatelet therapy?
Leonardo De Luca
Circulation. Cardiovascular Interventions
|
September 1, 2016
Percutaneous Treatment of Coronary Bifurcation Lesions: Is Simplicity the Ultimate Sophistication?
Leonardo De Luca
European Heart Journal Supplements : Journal of the European Society of Cardiology
|
May 1, 2023
Low-dose rivaroxaban: can cardiovascular events be reduced?
Leonardo De Luca
Giornale Italiano Di Cardiologia (2006)
|
January 15, 2019
[Five questions for the clinician after the publication of the COMPASS trial]
Leonardo De Luca
European Heart Journal. Cardiovascular Pharmacotherapy
|
June 15, 2021
Pre-treatment with dual antiplatelet therapy in non-ST-segment elevation acute coronary syndromes: landing from guidelines recommendations to real-world ground
Leonardo De Luca
Page
of 40